Name: Latest research reports of Ipca Laboratories Ltd. authored by Sharekhan and published by - Trendlyne research reports.
Item: Ipca Laboratories Ltd.
Rating: 5
Author: Sharekhan

Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Expensive Performer

1446.7500 -6.25 (-0.43%)

NSE Mar 25, 2025 15:31 PM

37.52% Gain from 52W Low

Volume: 227.6K

Ipca Laboratories Ltd.

30 Sep 2024

1446.75

-0.43%

Bayshore integration to unlock growth

Buy: Ipca Laboratories Ltd.

Target

Sharekhan

Ipca’s board would discuss the strategic integration of Bayshore Pharmaceuticals’ generics business into Unichem Pharma (USA) Inc on September 30, 2024.

Ipca Laboratories Ltd. has an average target of 1815.00 from 3 brokers.